150 related articles for article (PubMed ID: 26844747)
21. WHO takes major steps to make HIV treatment accessible.
J Adv Nurs; 2002 Sep; 39(6):517-8. PubMed ID: 12365403
[No Abstract] [Full Text] [Related]
22. Polypharmacy and the treatment of HIV/AIDS.
Bretzel R; Boeth J
J Am Pharm Assoc (Wash); 1996 Dec; NS36(12):722a-722e. PubMed ID: 8990757
[No Abstract] [Full Text] [Related]
23. Psychopharmacologic treatment of patients with HIV/AIDS.
Ferrando SJ
Curr Psychiatry Rep; 2009 Jun; 11(3):235-42. PubMed ID: 19470286
[TBL] [Abstract][Full Text] [Related]
24. Evidence-based guideline: Antiepileptic drug selection for people with HIV/AIDS: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Ad Hoc Task Force of the Commission on Therapeutic Strategies of the International League Against Epilepsy.
Birbeck GL; French JA; Perucca E; Simpson DM; Fraimow H; George JM; Okulicz JF; Clifford DB; Hachad H; Levy RH; ;
Neurology; 2012 Jan; 78(2):139-45. PubMed ID: 22218281
[TBL] [Abstract][Full Text] [Related]
25. Therapies. Confronting the limits of success.
Cohen J
Science; 2002 Jun; 296(5577):2320-4. PubMed ID: 12089422
[No Abstract] [Full Text] [Related]
26. New guidelines increase access to HIV/AIDS medication.
AORN J; 2002 Sep; 76(3):448. PubMed ID: 12382663
[No Abstract] [Full Text] [Related]
27. Appendix D: Summary of Evidence-based Guideline for Clinicians: Treatment of Nervous System Lyme Disease.
Continuum (Minneap Minn); 2015 Dec; 21(6 Neuroinfectious Disease):1773-4. PubMed ID: 26633793
[No Abstract] [Full Text] [Related]
28. ACTIS and ATIS: new resources for AIDS information, part two.
Fitzpatrick RB
Med Ref Serv Q; 2003; 22(1):31-8. PubMed ID: 12627689
[TBL] [Abstract][Full Text] [Related]
29. Task shifting in the public health sector--what is the evidence?
Wiysonge CS; Araoyinbo ID
S Afr Med J; 2008 Aug; 98(8):570, 572. PubMed ID: 18938684
[No Abstract] [Full Text] [Related]
30. Pharmacokinetic and other drug interactions in patients with AIDS.
Dasgupta A; Okhuysen PC
Ther Drug Monit; 2001 Dec; 23(6):591-605. PubMed ID: 11802090
[TBL] [Abstract][Full Text] [Related]
31. Federal panel backs early, aggressive HIV therapy.
Am J Health Syst Pharm; 1997 Aug; 54(15):1681, 1685-7. PubMed ID: 9262737
[No Abstract] [Full Text] [Related]
32. Reflections: neurology and the humanities: reflections for October.
Birbeck GL
Neurology; 2009 Oct; 73(15):1245-6. PubMed ID: 19822877
[No Abstract] [Full Text] [Related]
33. Antiretroviral therapy in HIV/AIDS: update from San Francisco.
Laurence J
AIDS Read; 2000 Mar; 10(3):133-4. PubMed ID: 10758008
[No Abstract] [Full Text] [Related]
34. Appendix B: Summary of Evidence-based Guideline for Clinicians: Treatment of Parenchymal Neurocysticercosis.
Continuum (Minneap Minn); 2015 Dec; 21(6 Neuroinfectious Disease):1768-9. PubMed ID: 26633791
[No Abstract] [Full Text] [Related]
35. HIV/AIDS in China. A new treatment campaign, but with limited weapons.
Cohen J
Science; 2004 Jun; 304(5676):1433. PubMed ID: 15178778
[No Abstract] [Full Text] [Related]
36. Experts plan to recommend immediate antiretroviral therapy for people with HIV.
O'Dowd A
BMJ; 2015 Jun; 350():h2963. PubMed ID: 26033619
[No Abstract] [Full Text] [Related]
37. Common HIV drug-drug interactions.
O'Brien LW
AIDS Read; 1999; 9(2):104-9. PubMed ID: 12728892
[TBL] [Abstract][Full Text] [Related]
38. [The status of and outlook for the creation of new preparations for the therapy and prevention of HIV infection and AIDS].
Ivanitskaia LP; Nosik DN; Bibikova MV; Iakushkina NI; Spiridonova IA; Grigor'ev VB; Lobach OA
Antibiot Khimioter; 1999; 44(10):39-45. PubMed ID: 10635421
[No Abstract] [Full Text] [Related]
39. [Can HIV/AIDS be healed with new therapies?].
Battegay M
Praxis (Bern 1994); 1997 May; 86(22):931-2. PubMed ID: 9289789
[No Abstract] [Full Text] [Related]
40. ACRC selected for study. AIDS Community Research Consortium.
AIDS Patient Care STDS; 1998 Feb; 12(2):150. PubMed ID: 11361919
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
